Springer Nature

Springer Nature reported currency-adjusted revenue growth of 6% to €940m for H1 2026 and an adjusted operating profit increase of 8% to €246m; the adjusted operating margin improved by 38 basis points. Free cash flow rose to €268m and net leverage fell to 1.6x. The research segment remains the growth driver with around 80% of revenue; Open Access and higher article publications drove the growth. Management raised the full-year outlook for currency-adjusted revenue growth to about 6% and cites AI initiatives as a strategic focus; the shares rose about 2.9%. » More on de.investing.com

Springer Nature has raised its forecast: organic revenue growth is now expected to be around 6% (previously 5–6%), and the operating margin is forecast to improve by at least 0.3 percentage points. In the first half, group revenue rose 1.5% to €939.8m (organic 6.2%) and adjusted operating income increased to €246.2m. Analysts highlighted the stronger numbers, the share price rose sharply, while net profit fell to €101.3m, in part due to higher taxes and currency effects. » More on finanzen.net

At the annual general meeting, Springer Nature approved a dividend of 0.83 EUR per share for fiscal year 2025 (total payout 25.90 million EUR), an increase of 538.46% from the previous year. The dividend yield for 2025 is 4.34% and the stock traded ex-dividend; FactSet expects an increase to 0.84 EUR for 2026 (yield 4.45%). Other key figures: market capitalization 3.998 billion EUR, P/E ratio 10.69, revenue 2025: 1.926 billion EUR, EPS 1.79 EUR. » More on finanzen.net